MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
Abstract Background Chemotherapeutic agents that modulate cell cycle checkpoints and/or tumor-specific pathways have shown immense promise in preclinical and clinical studies aimed at anti-cancer therapy. MASTL (Greatwall in Xenopus and Drosophila), a serine/threonine kinase controls the final G2/M...
Main Authors: | Srijayaprakash Babu Uppada, Saiprasad Gowrikumar, Rizwan Ahmad, Balawant Kumar, Bryan Szeglin, Xi Chen, J. Joshua Smith, Surinder K. Batra, Amar B. Singh, Punita Dhawan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-018-0848-3 |
Similar Items
-
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes
by: Minsung Kang, et al.
Published: (2021-07-01) -
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Carcinogenesis by Modulating Microtubule-Associated Serine/Threonine Kinase-like/Wnt/β-Catenin Signaling
by: Raju Lama Tamang, et al.
Published: (2023-07-01) -
Kinase-Independent Functions of MASTL in Cancer: A New Perspective on MASTL Targeting
by: James Ronald William Conway, et al.
Published: (2020-07-01) -
The Oncogenic Functions of MASTL Kinase
by: Kamila Marzec, et al.
Published: (2018-11-01) -
Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells
by: Susmita Barman, et al.
Published: (2021-04-01)